Papaverine: Clinical Trials

3 trials of Papaverine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Active not recruiting 1

Follow Papaverine: new trials by email Literature Review of Papaverine trials Research Report on Papaverine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
Biospecimen Collection, Computed Tomography, Consolidation Therapy - Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8
Phase 1RecruitingCity of Hope Medical Center362025-04-072026-07-22
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Carboplatin, Durvalumab, Paclitaxel - Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 1RecruitingOhio State University Comprehensive Cancer Center282021-12-062026-06-30
Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
Blood Oxygen Level Dependent Imaging, Papaverine Hydrochloride, Stereotactic Body Radiation Therapy - Lung Non-Small Cell Carcinoma
Phase 1Active not recruitingOhio State University Comprehensive Cancer Center192019-02-072026-10-16

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Ohio State University Comprehensive Cancer Center (2)  ·  City of Hope Medical Center (1)

Countries

United States (3)

Top investigators

Jeremey Brownstein, MD (1)  ·  Jeremy Brownstein, MD (1)  ·  Terence M Williams (1)

NIH funding

P30CA033572 (1), R01CA262388 (1), R01CA297752 (1)